302 related articles for article (PubMed ID: 37139365)
1. Gut distress and intervention
Moon Y
Front Public Health; 2023; 11():1098774. PubMed ID: 37139365
[TBL] [Abstract][Full Text] [Related]
2. Nutritional Modulation of Gut Microbiota Alleviates Severe Gastrointestinal Symptoms in a Patient with Post-Acute COVID-19 Syndrome.
Wang Y; Wu G; Zhao L; Wang W
mBio; 2022 Apr; 13(2):e0380121. PubMed ID: 35254129
[TBL] [Abstract][Full Text] [Related]
3. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
[TBL] [Abstract][Full Text] [Related]
4. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB
Front Immunol; 2021; 12():635471. PubMed ID: 33717181
[TBL] [Abstract][Full Text] [Related]
5. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
Xiang H; Liu QP
World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 - gastrointestinal and gut microbiota-related aspects.
Kaźmierczak-Siedlecka K; Vitale E; Makarewicz W
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10853-10859. PubMed ID: 33155247
[TBL] [Abstract][Full Text] [Related]
7. Coronavirus disease-2019 and the intestinal tract: An overview.
Alberca GGF; Solis-Castro RL; Solis-Castro ME; Alberca RW
World J Gastroenterol; 2021 Apr; 27(13):1255-1266. PubMed ID: 33833480
[TBL] [Abstract][Full Text] [Related]
8. Coronavirus disease 2019 and the gut-lung axis.
Zhou D; Wang Q; Liu H
Int J Infect Dis; 2021 Dec; 113():300-307. PubMed ID: 34517046
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal mucosal immunity and COVID-19.
Velikova T; Snegarova V; Kukov A; Batselova H; Mihova A; Nakov R
World J Gastroenterol; 2021 Aug; 27(30):5047-5059. PubMed ID: 34497434
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychiatric Ramifications of COVID-19: Short-Chain Fatty Acid Deficiency and Disturbance of Microbiota-Gut-Brain Axis Signaling.
Sajdel-Sulkowska EM
Biomed Res Int; 2021; 2021():7880448. PubMed ID: 34651049
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications.
Durairajan SSK; Singh AK; Saravanan UB; Namachivayam M; Radhakrishnan M; Huang JD; Dhodapkar R; Zhang H
Viruses; 2023 May; 15(6):. PubMed ID: 37376531
[TBL] [Abstract][Full Text] [Related]
12. Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters.
Sencio V; Machelart A; Robil C; Benech N; Hoffmann E; Galbert C; Deryuter L; Heumel S; Hantute-Ghesquier A; Flourens A; Brodin P; Infanti F; Richard V; Dubuisson J; Grangette C; Sulpice T; Wolowczuk I; Pinet F; Prévot V; Belouzard S; Briand F; Duterque-Coquillaud M; Sokol H; Trottein F
Gut Microbes; 2022; 14(1):2018900. PubMed ID: 34965194
[TBL] [Abstract][Full Text] [Related]
13. Profiles of gut microbiota associated with clinical outcomes in patients with different stages of SARS-CoV-2 infection.
Krasaewes K; Chaiwarith R; Chattipakorn N; Chattipakorn SC
Life Sci; 2023 Nov; 332():122136. PubMed ID: 37783267
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications.
Zhang F; Lau RI; Liu Q; Su Q; Chan FKL; Ng SC
Nat Rev Gastroenterol Hepatol; 2023 May; 20(5):323-337. PubMed ID: 36271144
[TBL] [Abstract][Full Text] [Related]
15. Symptomatology and microbiology of the gastrointestinal tract in post-COVID conditions.
Norouzi Masir M; Shirvaliloo M
JGH Open; 2022 Aug; 6(10):667-76. PubMed ID: 36247234
[TBL] [Abstract][Full Text] [Related]
16. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.
Vodnar DC; Mitrea L; Teleky BE; Szabo K; Călinoiu LF; Nemeş SA; Martău GA
Front Cell Infect Microbiol; 2020; 10():575559. PubMed ID: 33363049
[TBL] [Abstract][Full Text] [Related]
17. Temporal landscape of human gut RNA and DNA virome in SARS-CoV-2 infection and severity.
Zuo T; Liu Q; Zhang F; Yeoh YK; Wan Y; Zhan H; Lui GCY; Chen Z; Li AYL; Cheung CP; Chen N; Lv W; Ng RWY; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
Microbiome; 2021 Apr; 9(1):91. PubMed ID: 33853691
[TBL] [Abstract][Full Text] [Related]
18. Roles of the gut microbiota in severe SARS-CoV-2 infection.
Liu Y; Kuang D; Li D; Yang J; Yan J; Xia Y; Zhang F; Cao H
Cytokine Growth Factor Rev; 2022 Feb; 63():98-107. PubMed ID: 35131164
[TBL] [Abstract][Full Text] [Related]
19. Mild SARS-CoV-2 infection results in long-lasting microbiota instability.
Upadhyay V; Suryawanshi RK; Tasoff P; McCavitt-Malvido M; Kumar RG; Murray VW; Noecker C; Bisanz JE; Hswen Y; Ha CWY; Sreekumar B; Chen IP; Lynch SV; Ott M; Lee S; Turnbaugh PJ
mBio; 2023 Aug; 14(4):e0088923. PubMed ID: 37294090
[TBL] [Abstract][Full Text] [Related]
20. Exploring gut-lung axis crosstalk in SARS-CoV-2 infection: Insights from a hACE2 mouse model.
Zhang Y; Ma Y; Sun W; Zhou X; Wang R; Xie P; Dai L; Gao Y; Li J
J Med Virol; 2024 Jan; 96(1):e29336. PubMed ID: 38193530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
